AMAG Pharmaceuticals, Inc. (AMAG) Tops Q4 EPS by 25c
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Net loss before income taxes: 21.27M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Net loss before income taxes: 21.27M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported Q4 EPS of ($0.87), $0.25 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $14.72 million.
For earnings history and earnings-related data on AMAG Pharmaceuticals, Inc. (AMAG) click here.
For earnings history and earnings-related data on AMAG Pharmaceuticals, Inc. (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gordon Haskett cuts TJX Companies rating to Accumulate
- NexPoint Residential Trust (NXRT) Reiterated at Market Perform by Citizens Post Guidance Cut
- NetEase (NTES) Misses Q2 EPS by 352c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
